The Prostate Cancer Clinical Trials Consortium (PCCTC) is a network of over 112 participating institutions sponsored by the Prostate Cancer Foundation and the Department of Defense Prostate Cancer Research Program (PCF), with its Coordinating Center headquartered at Memorial Sloan Kettering Cancer Center. Today the PCCTC is recognized as the nation’s premier multicenter clinical research organization specializing in cutting-edge prostate cancer research.

Capitalizing on their long histories of collaboration, scientific expertise, and unique institutional resources, members of the PCCTC work together on a single mission: to design, implement, and complete innovative hypothesis-driven trials in prostate cancer, translating scientific discoveries to improved standards of care for patients.

To facilitate this objective, the Coordinating Center has created a new paradigm for collaborative drug development, implementing an organizational structure that allows transparent project co-development between investigators, clinical sites, and research sponsors. The PCCTC’s comprehensive suite of contract research/site management organization (CRO/SMO) services and world-class scientific expertise streamline and accelerate the activation, accrual, and completion of multicenter clinical trials.

Patients and advocates wanting to learn more about prostate cancer and available PCCTC clinical trials can visit the consortium’s Web site at www.pcctc.org. Sponsors interested in collaborating with the PCCTC are encouraged to email [email protected] for more information.